• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data on how to get adhd medication uk long-term exposure may affect the pregnant fetus.

A recent study published in Molecular Psychiatry shows that children exposed to adhd sleep medication medication during the uterus don't develop neurological developmental disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the advantages of using them against the risks to the fetus. Doctors don't have the data needed to make unequivocal recommendations however they can provide information on the risks and benefits to aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers used a vast population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists examined the cases to ensure correct case classification and to minimize the chance of bias.

However, the researchers' study was not without its flaws. In particular, they were unable to separate the effects of the medication from the effects of the underlying disorder. This makes it difficult to know whether the small associations observed in the groups that were exposed are due to the use of medication or comorbidities that cause confusion. The researchers did not examine the long-term effects for the offspring.

The study did find that babies whose mothers had taken ADHD medications during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or had stopped their medications before or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean section or having a baby born with a low Apgar score (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

Researchers suggest that the small risk of using adhd medication for women medications in early pregnancies could be offset by the more beneficial outcomes for both mother and baby of continuing treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping strategies that could reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether to continue or stop treatment during pregnancy is a question that more and more doctors confront. The majority of these decisions are made without solid and reliable evidence in either case, which means that doctors must weigh what they know about their experiences, the experiences of other doctors, and what research says on the topic as well as their own best judgment for each individual patient.

The issue of possible risks to the infant can be extremely difficult. The research on this subject is based on observations rather than controlled studies, and many of the findings are in conflict. most popular adhd medication studies focus on live births, which may underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in the journal club addresses these shortcomings by analyzing information on deceased and live births.

Conclusion: While some studies have shown an association between inattentive adhd medication uk medications and certain birth defects however, other studies haven't established a link. The majority of studies show an unintended, or slight negative impact. In the end, a careful risk/benefit assessment is required in every instance.

For many women with ADHD who suffer from ADHD, the decision to discontinue medication is difficult if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. A decrease in medication could also affect the ability to drive safely and to perform work-related tasks which are crucial aspects of normal life for those suffering from ADHD.

She recommends women who are unsure about whether to continue or stop taking medication because of their pregnancy consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily life, and the benefits of keeping the current treatment regimen. It can also help women feel more confident in her decision. It is also worth noting that certain medications can pass through the placenta, therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the medication could be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about what impact the drugs might have on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge on this subject. Using two massive data sets researchers were able analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medications was linked to an increase in the risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study did not find any association between early use of medication and congenital anomalies like facial deformities or club feet. The results are in line with previous studies which showed a small, but significant increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, as many women begin to discontinue their ADHD medications.

Women who took ADHD medication during the first trimester were more likely need a caesarean or have a low Apgar after birth and had a baby that required help breathing after birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their study will inform physicians when they see pregnant women. The researchers suggest that, while discussing risks and benefits are important, the decision on whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that even though stopping the medication is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health issues among women who are pregnant or recently post-partum. Furthermore, research suggests that women who choose to stop taking their medication are more likely to experience a difficult time adapting to life without them following the birth of their baby.

Nursing

It can be a challenge to become a mother. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments, preparing for the arrival of their child and adjusting to new household routines are often faced with a number of difficulties. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in small amounts, so the risk for breastfeeding infant is minimal. However, the frequency of medication exposure to the newborn can vary depending on the dosage, frequency it is administered and the time of the day it is administered. In addition, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn isn't fully known.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication against the potential dangers to the fetus. As long as there is no more information, GPs should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

A increasing number of studies have shown that women can continue taking their ADHD medication while they are pregnant and nursing. In response, a rising number of patients are choosing to do this. They have found through consultation with their doctors, that the benefits of keeping their current medication far outweigh any potential risks.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should review their medications with their physician and discuss the pros and cons of continued treatment, including non stimulant adhd medication-pharmacological management strategies. Psychoeducation is also required to help pregnant women with ADHD be aware of the symptoms and underlying disorder. They should also be informed about treatment options and build the coping mechanisms. This should include an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration, and, if needed modifications to the medication regime.